11.71
Finanzdaten der Kailera Therapeutics Inc-Aktie (KLRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 |
| Periodenlänge | 3 Monate | 3 Monate |
| Operating Expenses |
43.37%
121.37
|
84.66 |
| Operating Income/Loss |
43.37%
-121.37
|
-84.66 |
| Nonoperating Income/Loss |
10.07
|
- |
| Net Income/Loss |
41.14%
-111.31
|
-78.86 |
| Basic Average Shares |
473.02K%
102.23
|
0.0216 |
| Diluted Average Shares |
473.02K%
102.23
|
0.0216 |
| Basic Earnings Per Share |
99.97%
-1.09
|
-3,650.00 |
| Diluted Earnings Per Share |
99.97%
-1.09
|
-3,650.00 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):